H. Autorité-de-santé-durme, Y. Verhamme, K. Stijnen, and T. , Prevalence, Incidence, and Lifetime Risk for the Development of COPD in the Elderly, Chest, vol.135, issue.2, pp.368-377, 2006.
DOI : 10.1378/chest.08-0684

E. Crisafulli, S. Costi, and F. Luppi, Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation, Thorax, vol.63, issue.6, pp.487-492, 2008.
DOI : 10.1136/thx.2007.086371

B. Celli, N. Thomas, and J. Anderson, Effect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary Disease, American Journal of Respiratory and Critical Care Medicine, vol.178, issue.4, pp.332-338, 2008.
DOI : 10.1164/rccm.200712-1869OC

D. Tashkin, B. Celli, and S. Senn, A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease, New England Journal of Medicine, vol.359, issue.15, pp.1543-1554, 2008.
DOI : 10.1056/NEJMoa0805800

V. Peinado, J. Barbera, and J. Ramirez, Endothelial dysfunction in pulmonary arteries of patients with mild COPD, Am J Physiol, vol.274, pp.908-913, 1998.

R. Barr, S. Mesia-vela, and J. Austin, Impaired Flow-mediated Dilation Is Associated with Low Pulmonary Function and Emphysema in Ex-smokers, American Journal of Respiratory and Critical Care Medicine, vol.176, issue.12, pp.1200-1207, 2007.
DOI : 10.1164/rccm.200707-980OC

P. Palange, U. Testa, and A. Huertas, Circulating haemopoietic and endothelial progenitor cells are decreased in COPD, European Respiratory Journal, vol.27, issue.3, pp.529-541, 2006.
DOI : 10.1183/09031936.06.00120604

V. Vaidyula, G. Criner, and C. Grabianowski, Circulating tissue factor procoagulant activity is elevated in stable moderate to severe chronic obstructive pulmonary disease, Thrombosis Research, vol.124, issue.3, pp.259-261, 2009.
DOI : 10.1016/j.thromres.2008.12.030

P. Kaczmarek, K. Sladek, and E. Stepien, Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease. Beneficial effects of simvastatin treatment, Thromb Haemost, vol.102, pp.1176-1182, 2009.

R. Sabit, P. Thomas, and D. Shale, The Effects of Hypoxia on Markers of Coagulation and Systemic Inflammation in Patients With COPD, Chest, vol.138, issue.1, pp.47-51, 2010.
DOI : 10.1378/chest.09-2764

I. Tillie-leblond, C. Marquette, and T. Perez, Pulmonary Embolism in Patients with Unexplained Exacerbation of Chronic Obstructive Pulmonary Disease: Prevalence and Risk Factors, Annals of Internal Medicine, vol.144, issue.6, pp.390-396, 2006.
DOI : 10.7326/0003-4819-144-6-200603210-00005

H. Gunen, G. Gulbas, and E. In, Venous thromboemboli and exacerbations of COPD, European Respiratory Journal, vol.35, issue.6, pp.1243-1248, 2010.
DOI : 10.1183/09031936.00120909

A. Chaouat, R. Naeije, and E. Weitzenblum, Pulmonary hypertension in COPD, European Respiratory Journal, vol.32, issue.5, pp.1371-1385, 2008.
DOI : 10.1183/09031936.00015608

URL : https://hal.archives-ouvertes.fr/hal-00596924

A. Chaouat, A. Bugnet, and N. Kadaoui, Severe Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease, American Journal of Respiratory and Critical Care Medicine, vol.172, issue.2, pp.189-194, 2005.
DOI : 10.1164/rccm.200401-006OC

S. Jyothula and Z. Safdar, Update on pulmonary hypertension complicating chronic obstructive pulmonary disease, Int J Chron Obstruct Pulmon Dis, vol.4, pp.351-363, 2009.

M. Oswald-mammosser, E. Weitzenblum, and E. Quoix, Prognostic Factors in COPD Patients Receiving Long-term Oxygen Therapy, Chest, vol.107, issue.5, pp.1193-1198, 1995.
DOI : 10.1378/chest.107.5.1193

R. Kessler and M. Oswald-mammosser, DOES LUNG VOLUME REDUCTION SURGERY COMPROMISE THE PULMONARY CIRCULATION?, American Journal of Respiratory and Critical Care Medicine, vol.160, issue.4, pp.1429-1430, 1999.
DOI : 10.1164/ajrccm.160.4.16040_3

M. Fisher, P. Forfia, and E. Chamera, Accuracy of Doppler Echocardiography in the Hemodynamic Assessment of Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.179, issue.7, pp.615-621, 2009.
DOI : 10.1164/rccm.200811-1691OC

E. Weitzenblum, A. Sautegeau, and M. Ehrhart, Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease, Am Rev Respir Dis, vol.131, pp.493-498, 1985.

D. Sin and S. Man, Chronic Obstructive Pulmonary Disease as a Risk Factor for Cardiovascular Morbidity and Mortality, Proceedings of the American Thoracic Society, vol.2, issue.1, pp.8-11, 2005.
DOI : 10.1513/pats.200404-032MS

G. Hansson, Inflammation, Atherosclerosis, and Coronary Artery Disease, New England Journal of Medicine, vol.352, issue.16, pp.1685-1695, 2005.
DOI : 10.1056/NEJMra043430

W. Macnee, J. Maclay, and D. Mcallister, Cardiovascular Injury and Repair in Chronic Obstructive Pulmonary Disease, Proceedings of the American Thoracic Society, vol.5, issue.8, pp.824-833, 2008.
DOI : 10.1513/pats.200807-071TH

P. Eickhoff, A. Valipour, and D. Kiss, Determinants of Systemic Vascular Function in Patients with Stable Chronic Obstructive Pulmonary Disease, American Journal of Respiratory and Critical Care Medicine, vol.178, issue.12, pp.1211-1218, 2008.
DOI : 10.1164/rccm.200709-1412OC

P. Brekke, T. Omland, and P. Smith, Underdiagnosis of myocardial infarction in COPD ??? Cardiac Infarction Injury Score (CIIS) in patients hospitalised for COPD exacerbation, Respiratory Medicine, vol.102, issue.9, pp.1243-1247, 2008.
DOI : 10.1016/j.rmed.2008.04.010

D. Sin and S. Man, Why Are Patients With Chronic Obstructive Pulmonary Disease at Increased Risk of Cardiovascular Diseases?: The Potential Role of Systemic Inflammation in Chronic Obstructive Pulmonary Disease, Circulation, vol.107, issue.11, pp.1514-1519, 2003.
DOI : 10.1161/01.CIR.0000056767.69054.B3

P. Calverley, J. Andeson, and B. Celli, Cardiovascular events in patients with COPD: TORCH Study results, Thorax, vol.65, issue.8, pp.719-725, 2010.
DOI : 10.1136/thx.2010.136077

S. Singh, Y. Loke, and C. Furberg, Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systemic review, JAMA, vol.301, pp.1227-1230, 2008.

S. Singh, Y. Loke, and P. Enright, Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials, BMJ, vol.342, issue.jun14 1, p.31, 2011.
DOI : 10.1136/bmj.d3215

L. Jemtel, T. Padeletti, M. Jelic, and S. , Diagnostic and Therapeutic Challenges in Patients With Coexistent Chronic Obstructive Pulmonary Disease and Chronic Heart Failure, Journal of the American College of Cardiology, vol.49, issue.2, pp.171-180, 2007.
DOI : 10.1016/j.jacc.2006.08.046

X. Freixa, K. Portillo, and C. Paré, Echocardiographic abnormalities in patients with COPD at their first hospital admission, European Respiratory Journal, vol.41, issue.4, pp.784-791, 2013.
DOI : 10.1183/09031936.00222511

F. Rutten, M. Cramer, and J. Lammers, Heart failure and chronic obstructive pulmonary disease: An ignored combination?, European Journal of Heart Failure, vol.26, issue.7, pp.707-711, 2006.
DOI : 10.1016/j.ejheart.2006.01.010

S. Sidney, M. Sorel, and C. Quesenberry, COPD and Incident Cardiovascular Disease Hospitalizations and Mortality: Kaiser Permanente Medical Care Program, Chest, vol.128, issue.4, pp.2068-2075, 2005.
DOI : 10.1378/chest.128.4.2068

L. Garcia-rodriguez, M. Wallander, and E. Martin-merino, Heart failure, myocardial infarction, lung cancer and death in COPD patients: A UK primary care study, Respiratory Medicine, vol.104, issue.11, pp.1691-1699, 2010.
DOI : 10.1016/j.rmed.2010.04.018

D. Blois, J. Simard, S. Atar, and D. , COPD Predicts Mortality in HF: The Norwegian Heart Failure Registry, Journal of Cardiac Failure, vol.16, issue.3, pp.226-229, 2010.
DOI : 10.1016/j.cardfail.2009.12.002

J. Mascarenhas, P. Lourenço, and R. Lopes, Chronic obstructive pulmonary disease in heart failure. Prevalence, therapeutic and prognostic implications, American Heart Journal, vol.155, issue.3, pp.521-525, 2008.
DOI : 10.1016/j.ahj.2007.10.040

A. Jabbour, P. Macdonald, and A. Keogh, Differences Between Beta-Blockers in Patients With Chronic Heart Failure and Chronic Obstructive Pulmonary Disease, Journal of the American College of Cardiology, vol.55, issue.17, pp.1780-1787, 2010.
DOI : 10.1016/j.jacc.2010.01.024

K. Ho, J. Pinsky, and W. Kannel, The epidemiology of heart failure: The Framingham Study, Journal of the American College of Cardiology, vol.22, issue.4, pp.6-13, 1993.
DOI : 10.1016/0735-1097(93)90455-A

W. Flu, Y. Van-gestel, and J. Van-kuijk, Co-existence of COPD and left ventricular dysfunction in vascular surgery patients, Respiratory Medicine, vol.104, issue.5, pp.690-696, 2010.
DOI : 10.1016/j.rmed.2009.11.013

R. Loganathan, D. Stover, and W. Shi, Prevalence of COPD in Women Compared to Men Around the Time of Diagnosis of Primary Lung Cancer, Chest, vol.129, issue.5, pp.1305-1312, 2006.
DOI : 10.1378/chest.129.5.1305

R. Young, R. Hopkins, and T. Christmas, COPD prevalence is increased in lung cancer, independent of age, sex and smoking history, European Respiratory Journal, vol.34, issue.2, pp.380-386, 2009.
DOI : 10.1183/09031936.00144208

V. Kiri, J. Soriano, and G. Visick, Recent trends in lung cancer and its association with COPD: an analysis using the UK GP Research Database, Primary Care Respiratory Journal, vol.19, issue.1, pp.57-61, 2010.
DOI : 10.4104/pcrj.2009.00048

D. Mannino, S. Aguayo, and T. Petty, Low Lung Function and Incident Lung Cancer in the United States, Archives of Internal Medicine, vol.163, issue.12, pp.1475-1480, 2003.
DOI : 10.1001/archinte.163.12.1475

J. De-torres, J. Marín, and C. Casanova, Lung cancer in patients with COPD: incidence and predicting factors

M. Turner, Y. Chen, and D. Krewski, Chronic Obstructive Pulmonary Disease Is Associated with Lung Cancer Mortality in a Prospective Study of Never Smokers, American Journal of Respiratory and Critical Care Medicine, vol.176, issue.3, pp.285-290, 2007.
DOI : 10.1164/rccm.200612-1792OC

R. Young and R. Hopkins, How the genetics of lung cancer may overlap with COPD, Respirology, vol.355, issue.12 Suppl., pp.1047-1055, 2011.
DOI : 10.1111/j.1440-1843.2011.02019.x

B. Cohen, E. Diamond, and C. Graves, A common familial component in lung cancer and chronic obstructive pulmonary disease, Lancet, vol.2, pp.523-526, 1977.

R. Young, R. Hopkins, and B. Hay, Lung cancer gene associated with COPD: triple whammy or possible confounding effect?, European Respiratory Journal, vol.32, issue.5, pp.1158-1164, 2008.
DOI : 10.1183/09031936.00093908

A. Schwartz and J. Ruckdeschel, Familial Lung Cancer, American Journal of Respiratory and Critical Care Medicine, vol.173, issue.1, pp.16-22, 2006.
DOI : 10.1164/rccm.200502-235PP

R. Young, C. Whittington, and R. Hopkins, Chromosome 4q31 locus in COPD is also associated with lung cancer, European Respiratory Journal, vol.36, issue.6, pp.1375-1382, 2010.
DOI : 10.1183/09031936.00033310

A. Punturieri, E. Szabo, and T. Croxton, Lung Cancer and Chronic Obstructive Pulmonary Disease: Needs and Opportunities for Integrated Research, JNCI Journal of the National Cancer Institute, vol.101, issue.8, pp.554-559, 2009.
DOI : 10.1093/jnci/djp023

H. Yao and I. Rahman, Current concepts on the role of inflammation in COPD and lung cancer, Current Opinion in Pharmacology, vol.9, issue.4, pp.375-383, 2009.
DOI : 10.1016/j.coph.2009.06.009

D. Aberle and A. Adams, Reduced lung-cancer mortality with low-dose computed tomographic screening, N Engl J Med, vol.365, pp.395-409, 2011.

A. Brunelli, A. Charloux, and C. Bolliger, ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy), European Respiratory Journal, vol.34, issue.1, pp.17-41, 2009.
DOI : 10.1183/09031936.00184308

E. Wagena, R. Van-der-meer, and R. Ostelo, The efficacy of smoking cessation strategies in people with chronic obstructive pulmonary disease: results from a systematic review, Respiratory Medicine: COPD Update, vol.1, issue.1, pp.805-815, 2004.
DOI : 10.1016/j.rmedu.2004.12.004

D. Tashkin, S. Rennard, and J. Hays, Effects of Varenicline on Smoking Cessation in Patients With Mild to Moderate COPD, Chest, vol.139, issue.3, pp.591-599, 2011.
DOI : 10.1378/chest.10-0865

P. Wu, K. Wilson, and P. Dimoulas, Effectiveness of smoking cessation therapies: a systematic review and meta-analysis, BMC Public Health, vol.335, issue.1, pp.300-59, 2006.
DOI : 10.1056/NEJM199612123352402

T. Parimon, J. Chien, and C. Bryson, Inhaled Corticosteroids and Risk of Lung Cancer among Patients with Chronic Obstructive Pulmonary Disease, American Journal of Respiratory and Critical Care Medicine, vol.175, issue.7, pp.712-719, 2007.
DOI : 10.1164/rccm.200608-1125OC

V. Kiri, L. Fabbri, and K. Davis, Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking, Respiratory Medicine, vol.103, issue.1, pp.85-90, 2009.
DOI : 10.1016/j.rmed.2008.07.024

R. Yao, Y. Wang, and W. Lemon, Budesonide exerts its chemopreventive efficacy during mouse lung tumorigenesis by modulating gene expressions, Oncogene, vol.23, issue.46, pp.7746-7752, 2004.
DOI : 10.1038/sj.onc.1207985

B. Sprague, A. Trentham-dietz, and B. Klein, Physical Activity, White Blood Cell Count, and Lung Cancer Risk in a Prospective Cohort Study, Cancer Epidemiology Biomarkers & Prevention, vol.17, issue.10, pp.2714-2722, 2008.
DOI : 10.1158/1055-9965.EPI-08-0042

J. Regvat, A. Zmitek, and M. Vegnuti, Anxiety and Depression during Hospital Treatment of Exacerbation of Chronic Obstructive Pulmonary Disease, Journal of International Medical Research, vol.67, issue.3, pp.1028-1038, 2011.
DOI : 10.1164/ajrccm.166.1.at1102

C. Spitzer, S. Gläser, and H. Grabe, Mental health problems, obstructive lung disease and lung function: Findings from the general population, Journal of Psychosomatic Research, vol.71, issue.3, pp.174-179, 2011.
DOI : 10.1016/j.jpsychores.2011.03.005

C. Schneider, S. Jick, and U. Bothner, COPD and the Risk of Depression, Chest, vol.137, issue.2, pp.341-347, 2010.
DOI : 10.1378/chest.09-0614

M. Kunik, Surprisingly High Prevalence of Anxiety and Depression in Chronic Breathing Disorders, Chest, vol.127, issue.4, pp.1205-1211, 2005.
DOI : 10.1016/S0012-3692(15)34468-8

J. Van-manen, Risk of depression in patients with chronic obstructive pulmonary disease and its determinants, Thorax, vol.57, issue.5, pp.412-416, 2002.
DOI : 10.1136/thorax.57.5.412

T. Abrams, M. Vaughan-sarrazin, V. Weg, and M. , Acute Exacerbations of Chronic Obstructive Pulmonary Disease and the Effect of Existing Psychiatric Comorbidity on Subsequent Mortality, Psychosomatics, vol.52, issue.5, pp.441-449, 2011.
DOI : 10.1016/j.psym.2011.03.005

T. Ng, M. Niti, and T. Wan-cheng, Depressive Symptoms and Chronic Obstructive Pulmonary Disease, Archives of Internal Medicine, vol.167, issue.1, pp.60-67, 2007.
DOI : 10.1001/archinte.167.1.60

R. Spitzer, K. Kroenke, and J. Williams, Validation and Utility of a Self-report Version of PRIME-MD<SUBTITLE>The PHQ Primary Care Study</SUBTITLE>, JAMA, vol.282, issue.18, pp.1737-1744, 1999.
DOI : 10.1001/jama.282.18.1737

H. Koenig, H. Cohen, and D. Blazer, Profile of Depressive Symptoms in Younger and Older Medical Inpatients with Major Depression, Journal of the American Geriatrics Society, vol.32, issue.6 suppl, pp.1169-1176, 1993.
DOI : 10.1111/j.1532-5415.1993.tb07298.x

A. Yohannes, J. Roomi, and R. Baldwin, Depression in elderly outpatients with disabling chronic obstructive pulmonary disease, Age and Ageing, vol.27, issue.2, pp.155-160, 1998.
DOI : 10.1093/ageing/27.2.155

A. Zigmond and R. Snaith, The Hospital Anxiety and Depression Scale, Acta Psychiatrica Scandinavica, vol.141, issue.6, pp.361-370, 1983.
DOI : 10.1111/j.1600-0447.1983.tb09716.x

A. Incalzi and R. , Drawing impairment predicts mortality in severe COPD, Chest, vol.128, pp.62-69, 2006.

L. Graat-verboom, E. Wouters, and F. Smeenk, Current status of research on osteoporosis in COPD: a systematic review, European Respiratory Journal, vol.34, issue.1, pp.209-218, 2009.
DOI : 10.1183/09031936.50130408

P. Scanlon, J. Connett, and R. Wise, Loss of Bone Density with Inhaled Triamcinolone in Lung Health Study II, American Journal of Respiratory and Critical Care Medicine, vol.170, issue.12
DOI : 10.1164/rccm.200310-1349OC

G. Ferguson, P. Calverley, and J. Anderson, Prevalence and Progression of Osteoporosis in Patients With COPD, Chest, vol.136, issue.6, pp.1456-1465, 2009.
DOI : 10.1378/chest.08-3016

T. Mineo, V. Ambrogi, and D. Mineo, Bone Mineral Density Improvement After Lung Volume Reduction Surgery for Severe Emphysema, Chest, vol.127, issue.6, pp.1960-1966, 2005.
DOI : 10.1378/chest.127.6.1960

S. Maggi, P. Siviero, and S. Gonnelli, Osteoporosis Risk in Patients With Chronic Obstructive Pulmonary Disease: The EOLO Study, Journal of Clinical Densitometry, vol.12, issue.3, pp.345-352, 2009.
DOI : 10.1016/j.jocd.2009.05.003

A. Ionescu and E. Schoon, Osteoporosis in chronic obstructive pulmonary disease, European Respiratory Journal, vol.22, issue.Supplement 46, pp.64-75, 2003.
DOI : 10.1183/09031936.03.00004609

W. Janssens, R. Bouillon, and B. Claes, Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene, Thorax, vol.65, issue.3, pp.215-220, 2010.
DOI : 10.1136/thx.2009.120659

P. Barnes, Chronic Obstructive Pulmonary Disease: Effects beyond the Lungs, PLoS Medicine, vol.180, issue.3, pp.1000220-84, 2010.
DOI : 10.1371/journal.pmed.1000220.g001

A. Avenell, W. Gillespie, and L. Gillespie, Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis Randomized controlled trial of alendronate in airways disease and low bone mineral density, Cochrane Database Syst Rev Chron Respir Dis, vol.2, issue.1, pp.131-137, 2004.

J. Grossman, R. Gordon, and V. Ranganath, American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis, Arthritis Care & Research, vol.60, issue.Suppl 3, pp.1515-1526, 2010.
DOI : 10.1002/acr.20295

A. Schols, P. Soeters, and A. Dingemans, Prevalence and Characteristics of Nutritional Depletion in Patients with Stable COPD Eligible for Pulmonary Rehabilitation, American Review of Respiratory Disease, vol.147, issue.5, pp.1151-1156, 1993.
DOI : 10.1164/ajrccm/147.5.1151

B. Celli, C. Cote, and J. Marin, The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease, New England Journal of Medicine, vol.350, issue.10, pp.1005-1012, 2004.
DOI : 10.1056/NEJMoa021322

P. Wagner, Possible mechanisms underlying the development of cachexia in COPD, European Respiratory Journal, vol.31, issue.3, pp.492-501, 2008.
DOI : 10.1183/09031936.00074807

N. Cano, C. Pichard, and H. Roth, C-Reactive Protein and Body Mass Index Predict Outcome in End-Stage Respiratory Failure, Chest, vol.126, issue.2, pp.540-546, 2004.
DOI : 10.1378/chest.126.2.540

J. Vestbo, E. Prescott, and T. Almdal, Body Mass, Fat-Free Body Mass, and Prognosis in Patients with Chronic Obstructive Pulmonary Disease from a Random Population Sample, American Journal of Respiratory and Critical Care Medicine, vol.173, issue.1
DOI : 10.1164/rccm.200506-969OC

A. Schols, R. Broekhuizen, and C. Weling-scheepers, Body composition and mortality in chronic obstructive pulmonary disease, Respiratory Medicine: COPD Update, vol.1, issue.2, pp.53-59, 2005.
DOI : 10.1016/j.rmedu.2005.09.028

C. Landbo, E. Prescott, and P. Lange, Prognostic Value of Nutritional Status in Chronic Obstructive Pulmonary Disease, American Journal of Respiratory and Critical Care Medicine, vol.160, issue.6, pp.1856-1861, 1999.
DOI : 10.1164/ajrccm.160.6.9902115

E. Chailleux, J. Laaban, and D. Veale, Prognostic Value of Nutritional Depletion in Patients With COPD Treated by Long-term Oxygen Therapy, Chest, vol.123, issue.5, pp.1460-1466, 2003.
DOI : 10.1378/chest.123.5.1460

J. Soler-cataluna, L. Sanchez-sanchez, M. Garcia, and M. , Mid-Arm Muscle Area Is a Better Predictor of Mortality Than Body Mass Index in COPD, Chest, vol.128, issue.4, pp.2108-2115, 2005.
DOI : 10.1378/chest.128.4.2108

D. Wilson, R. Rogers, and M. Sanders, Nutritional intervention in malnourished patients with emphysema, Am Rev Respir Dis, vol.134, pp.672-677, 1986.

J. Eftymiou, J. Fleming, and C. Gomes, The Effect of Supplementary Oral Nutrition in Poorly Nourished Patients with Chronic Obstructive Pulmonary Disease, American Review of Respiratory Disease, vol.137, issue.5, pp.1075-1082, 1988.
DOI : 10.1164/ajrccm/137.5.1075

I. Fereira, D. Brooks, and Y. Lacasse, Nutritional Support for Individuals With COPD, Chest, vol.117, issue.3, pp.672-678, 2000.
DOI : 10.1378/chest.117.3.672

R. Broekhuizen, E. Wouters, and E. Creutzberg, Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease, Thorax, vol.60, issue.5, pp.376-382, 2005.
DOI : 10.1136/thx.2004.030858

E. Creutzberg, E. Wouters, and R. Mostert, A Role for Anabolic Steroids in the Rehabilitation of Patients With COPD?*, Chest, vol.124, issue.5, pp.1733-1742, 2003.
DOI : 10.1378/chest.124.5.1733

J. Weisberg, J. Wanger, and J. Olson, Megestrol Acetate Stimulates Weight Gain and Ventilation in Underweight COPD Patients, Chest, vol.121, issue.4, pp.1070-1078, 2002.
DOI : 10.1378/chest.121.4.1070

A. Schols, Nutritional rehabilitation: from pulmonary cachexia to sarcoPD, European Respiratory Journal, vol.33, issue.5, pp.949-950, 2009.
DOI : 10.1183/09031936.00011209

C. Pison, N. Cano, and C. Chérion, Multimodal nutritional rehabilitation improves clinical outcomes of malnourished patients with chronic respiratory failure: a randomised controlled trial, Thorax, vol.66, issue.11, pp.953-960, 2011.
DOI : 10.1136/thx.2010.154922

URL : https://hal.archives-ouvertes.fr/inserm-00696275

J. Ora, P. Laveneziana, and D. Ofir, Combined Effects of Obesity and Chronic Obstructive Pulmonary Disease on Dyspnea and Exercise Tolerance, American Journal of Respiratory and Critical Care Medicine, vol.180, issue.10, pp.964-971, 2009.
DOI : 10.1164/rccm.200904-0530OC

S. Jee, J. Sull, and J. Park, Body-Mass Index and Mortality in Korean Men and Women, New England Journal of Medicine, vol.355, issue.8, pp.779-787, 2006.
DOI : 10.1056/NEJMoa054017

J. Jordan and J. Mann, Obesity and Mortality in Persons with Obstructive Lung Disease Using Data from the NHANES III, Southern Medical Journal, vol.103, issue.4, pp.232-230, 2010.
DOI : 10.1097/SMJ.0b013e3181d394b4

K. Alberti, P. Zimmet, and J. Shaw, Metabolic Syndrome, Diabetic Medicine, vol.28, pp.469-480, 2006.
DOI : 10.1007/s00125-006-0266-8

D. Mannino, D. Thorn, and A. Swensen, Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD, European Respiratory Journal, vol.32, issue.4, pp.962-969, 2008.
DOI : 10.1183/09031936.00012408

J. Rodrigues, L. Smith, and C. , Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care, Thorax, vol.65, pp.956-962, 2010.

M. Cazzola, G. Bettoncelli, and E. Sessa, Prevalence of Comorbidities in Patients with Chronic Obstructive Pulmonary Disease, Respiration, vol.80, issue.2, pp.112-119, 2010.
DOI : 10.1159/000281880

E. Ghanassia, A. Jaussent, and M. Picot, Pr??valence de l???insulinor??sistance et du syndrome m??tabolique chez le sujet BPCO, Revue des Maladies Respiratoires, vol.23, issue.4, p.393, 2006.
DOI : 10.1016/S0761-8425(06)71611-4

H. , W. B. Kirsten, and A. , The metabolic syndrome in patients with chronic bronchitis and COPD, Chest, vol.136, issue.4, pp.1039-1046, 2009.

Y. Klevak, A. Manson, and J. , Asthma, chronic obstructive pulmonary disease, and type 2 diabetes in the Women's Health Study, Diabetes Res Clin Pract, vol.90, pp.365-371, 2010.

S. Ehrlich, C. Quesenberry, . Jr, and S. Van-den-eeden, Patients Diagnosed With Diabetes Are at Increased Risk for Asthma, Chronic Obstructive Pulmonary Disease, Pulmonary Fibrosis, and Pneumonia but Not Lung Cancer, Diabetes Care, vol.33, issue.1, pp.55-60, 2010.
DOI : 10.2337/dc09-0880

S. Seshasai, S. Kaptoge, and A. Thompson, Diabetes mellitus, fasting glucose and risk of cause specific death, N Engl J Med, vol.364, pp.829-841, 2011.

E. Janaway, C. Philips, and B. , Hyperglycemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of COPD, Thorax, vol.61, pp.284-289, 2006.

A. Parappil, B. Depczynski, and P. Collett, Effect of comorbid diabetes on length of stay and risk of death in patients admitted with acute exacerbations of COPD, Respirology, vol.26, issue.1, pp.918-922, 2010.
DOI : 10.1111/j.1440-1843.2010.01781.x

J. Manson, U. Ajani, and S. Liu, A prospective study of cigarette smoking and the incidence of diabetes mellitus among us male physicians, The American Journal of Medicine, vol.109, issue.7, pp.538-542, 2000.
DOI : 10.1016/S0002-9343(00)00568-4

S. Shoelson, J. Lee, and A. Goldfine, Inflammation and insulin resistance, Journal of Clinical Investigation, vol.116, issue.7, pp.1793-1801, 2006.
DOI : 10.1172/JCI29069

A. Pradhan, Obesity, Metabolic Syndrome, and Type 2 Diabetes: Inflammatory Basis of Glucose Metabolic Disorders, Nutrition Reviews, vol.65, issue.12, pp.152-156, 2007.
DOI : 10.1301/nr.2007.dec.S152-S156

L. Fabbri, F. Luppi, and B. Beghé, Complex chronic comorbidities of COPD, European Respiratory Journal, vol.31, issue.1, pp.204-212, 2008.
DOI : 10.1183/09031936.00114307

R. Tkacova, Systemic Inflammation in Chronic Obstructive Pulmonary Disease: May Adipose Tissue Play a Role? Review of the Literature and Future Perspectives, Mediators of Inflammation, vol.182, issue.1, p.585989, 2010.
DOI : 10.1152/ajplung.00487.2005

R. Walter, A. Beiser, and R. Givelber, Association between Glycemic State and Lung Function, American Journal of Respiratory and Critical Care Medicine, vol.167, issue.6, pp.911-916, 2003.
DOI : 10.1164/rccm.2203022

H. Yeh, N. Punjabi, and N. Wang, Cross-Sectional and Prospective Study of Lung Function in Adults With Type 2 Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study, Diabetes Care, vol.31, issue.4, pp.741-746, 2008.
DOI : 10.2337/dc07-1464

B. Van-den-borst, H. Gosker, and M. Zeegers, Pulmonary Function in Diabetes, Chest, vol.138, issue.2, pp.393-406, 2010.
DOI : 10.1378/chest.09-2622

N. Leone, D. Courbon, and F. Thomas, Lung Function Impairment and Metabolic Syndrome, American Journal of Respiratory and Critical Care Medicine, vol.179, issue.6, pp.509-516, 2009.
DOI : 10.1164/rccm.200807-1195OC

Y. Funakoshi, H. Omori, and S. Mihara, Association between Airflow Obstruction and the Metabolic Syndrome or Its Components in Japanese Men, Internal Medicine, vol.49, issue.19, pp.2093-2099, 2010.
DOI : 10.2169/internalmedicine.49.3882

K. Lam, R. Jordan, and C. Jiang, Airflow obstruction and metabolic syndrome: the Guangzhou Biobank Cohort Study, European Respiratory Journal, vol.35, issue.2, pp.317-323, 2010.
DOI : 10.1183/09031936.00024709

A. Cuvelier, Pathologies extra-thoraciques au cours de la BPCO, Revue des Maladies Respiratoires, vol.23, issue.5, pp.25-31, 2006.
DOI : 10.1016/S0761-8425(06)71991-X

M. Burt, G. Roberts, and N. Aguilar-loza, Continuous Monitoring of Circadian Glycemic Patterns In Patients Receiving Prednisolone For COPD, The Journal of Clinical Endocrinology & Metabolism, vol.96, issue.6, pp.1789-1796, 2011.
DOI : 10.1210/jc.2010-2729

S. Suissa, A. Kezouh, and P. Ernst, Inhaled Corticosteroids and the Risks of Diabetes Onset and Progression, The American Journal of Medicine, vol.123, issue.11, pp.1001-1006, 2010.
DOI : 10.1016/j.amjmed.2010.06.019

M. Lemyze, J. Baudry, and F. Collet, Life threatening lactic acidosis Reality of severe metformin induced lactic acidosis in the absence of chronic renal impairment, BMJ J Med, vol.340, issue.5, pp.185-190, 2008.

G. Jones, J. Macklin, and W. Alexander, Contraindications to the use of metformin, BMJ, vol.326, issue.7379, pp.4-5, 2003.
DOI : 10.1136/bmj.326.7379.4

T. Sulkin, D. Bosman, and A. Krentz, Contraindications to Metformin Therapy in Patients With NIDDM, Diabetes Care, vol.20, issue.6, pp.925-928, 1997.
DOI : 10.2337/diacare.20.6.925

A. Holstein, D. Nahrwold, and S. Hinze, Contra-indications to metformin therapy are largely disregarded, Diabetic Medicine, vol.21, issue.8, pp.692-696, 1999.
DOI : 10.1001/archinte.152.11.2333

R. Rachmani, I. Slavachevski, and Z. Levi, Metformin in patients with type 2 diabetes mellitus: reconsideration of traditional contraindications, European Journal of Internal Medicine, vol.13, issue.7, pp.428-433, 2002.
DOI : 10.1016/S0953-6205(02)00131-0

I. Berlo-van-de-laar, C. Vermeij, and C. Doorenbos, Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements, Journal of Clinical Pharmacy and Therapeutics, vol.5, issue.3, pp.376-382, 2011.
DOI : 10.1111/j.1365-2710.2010.01192.x

A. Heikens, J. Erkelens, and D. , Metformin and lactic acidosis: cause or coincidence? A review of case reports, J Intern Med, vol.255, pp.179-187, 2004.

Y. Scale and J. Harvey, Diabetes, metformin and lactic acidosis, Clinical Endocrinology, vol.326, issue.2, pp.191-196, 2011.
DOI : 10.1111/j.1365-2265.2010.03891.x

R. Hopkins, R. Eaton, and T. , Pharmacological actions of statins: potential utility in COPD, Eur Respir J, vol.114, pp.222-232, 2009.

P. Barnes and B. Celli, Systemic manifestations and comorbidities of COPD, European Respiratory Journal, vol.33, issue.5, pp.1165-1185, 2009.
DOI : 10.1183/09031936.00128008

G. Mancini, M. Etminan, and B. Zhang, Reduction of Morbidity and Mortality by Statins, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin Receptor Blockers in Patients With Chronic Obstructive Pulmonary Disease, Journal of the American College of Cardiology, vol.47, issue.12, pp.2554-2560, 2006.
DOI : 10.1016/j.jacc.2006.04.039

F. Rutten, N. Zuithoff, and E. Hak, ??-Blockers May Reduce Mortality and Risk of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease, Archives of Internal Medicine, vol.170, issue.10, pp.880-887, 2010.
DOI : 10.1001/archinternmed.2010.112

W. Cormick, L. Olson, and M. Hensley, Nocturnal hypoxaemia and quality of sleep in patients with chronic obstructive lung disease., Thorax, vol.41, issue.11, pp.846-854, 1986.
DOI : 10.1136/thx.41.11.846

M. Klink, R. Dodge, and S. Quan, The Relation of Sleep Complaints to Respiratory Symptoms in a General Population, Chest, vol.105, issue.1, pp.151-154, 1994.
DOI : 10.1378/chest.105.1.151

R. Dodge, M. Cline, and S. Quan, The Natural History of Insomnia and Its Relationship to Respiratory Symptoms, Archives of Internal Medicine, vol.155, issue.16, pp.1797-1800, 1995.
DOI : 10.1001/archinte.1995.00430160145014

M. Sanders, A. Newman, and C. Haggerty, Sleep and Sleep-disordered Breathing in Adults with Predominantly Mild Obstructive Airway Disease, American Journal of Respiratory and Critical Care Medicine, vol.167, issue.1, pp.7-14, 2003.
DOI : 10.1164/rccm.2203046

S. Krachman, O. Minai, and S. Scharf, Sleep Abnormalities and Treatment in Emphysema, Proceedings of the American Thoracic Society, vol.5, issue.4, pp.536-542, 2008.
DOI : 10.1513/pats.200708-134ET

S. Krachman, W. Chatila, and U. Martin, Physiologic Correlates of Sleep Quality in Severe Emphysema, COPD: Journal of Chronic Obstructive Pulmonary Disease, vol.64, issue.7, pp.182-188, 2011.
DOI : 10.1017/S0317167100008957

A. Valipour, P. Lavie, and H. Lothaller, Sleep profile and symptoms of sleep disorders in patients with stable mild to moderate chronic obstructive pulmonary disease, Sleep Medicine, vol.12, issue.4, pp.367-372, 2011.
DOI : 10.1016/j.sleep.2010.08.017

R. Budhiraja, T. Roth, and D. Hudgel, Prevalence and polysomnographic correlates of insomnia comorbid with medical disorders, Sleep, vol.34, pp.859-867, 2011.

J. Wolfe, L. Lu, and B. , Hyperinflation is associated with lower sleep efficiency in COPD with co-existent obstructive sleep apnea, COPD, vol.6, pp.441-445, 2009.

S. Krachman, W. Chatila, and U. Martin, Effects of Lung Volume Reduction Surgery on Sleep Quality and Nocturnal Gas Exchange in Patients With Severe Emphysema, Chest, vol.128, issue.5, pp.3221-3228, 2005.
DOI : 10.1378/chest.128.5.3221

C. Fergusson, W. Eaton, and T. , Isolated nocturnal desaturation in COPD: prevalence and impact on quality of life and sleep, Thorax, vol.64, pp.133-138, 2009.

D. Coco, A. Mattaliano, L. Coco, and A. , Increased frequency of restless legs syndrome in chronic obstructive pulmonary disease patients, Sleep Medicine, vol.10, issue.5, pp.572-576, 2009.
DOI : 10.1016/j.sleep.2008.04.014

S. Scharf, N. Maimon, and T. Simon-tuval, Sleep quality predicts quality of life in chronic obstructive pulmonary disease, International Journal of Chronic Obstructive Pulmonary Disease, vol.6, pp.1-12, 2010.
DOI : 10.2147/COPD.S15666

A. Chaouat, E. Weitzenblum, and R. Kessler, A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients, European Respiratory Journal, vol.14, issue.5, pp.1002-1008, 1999.
DOI : 10.1183/09031936.99.14510029

E. Fletcher, R. Luckett, and S. Goodnight-white, above 60 mm Hg, American Review of Respiratory Disease, vol.145, issue.5, pp.1070-1076, 1992.
DOI : 10.1164/ajrccm/145.5.1070

W. Mcnicholas, P. Calverley, and A. Lee, Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD, European Respiratory Journal, vol.23, issue.6, pp.825-831, 2004.
DOI : 10.1183/09031936.04.00085804

S. Ryan, L. Doherty, and C. Rock, Effects of Salmeterol on Sleeping Oxygen Saturation in Chronic Obstructive Pulmonary Disease, Respiration, vol.79, issue.6, pp.475-481, 2010.
DOI : 10.1159/000235619

J. Donohue, C. Fogarty, and J. Lötvall, Once-Daily Bronchodilators for Chronic Obstructive Pulmonary Disease, American Journal of Respiratory and Critical Care Medicine, vol.182, issue.2, pp.155-162, 2010.
DOI : 10.1164/rccm.200910-1500OC

O. Kornmann, R. Dahl, and S. Centanni, Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison, European Respiratory Journal, vol.37, issue.2, pp.273-279, 2011.
DOI : 10.1183/09031936.00045810

P. Wijkstra, Y. Lacasse, and G. Guyatt, A Meta-analysis of Nocturnal Noninvasive Positive Pressure Ventilation in Patients With Stable COPD, Chest, vol.124, issue.1, pp.337-343, 2003.
DOI : 10.1378/chest.124.1.337

E. Clini, C. Sturani, and A. Rossi, The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients, European Respiratory Journal, vol.20, issue.3, pp.529-538, 2002.
DOI : 10.1183/09031936.02.02162001

R. Mcevoy, R. Pierce, and D. Hillman, Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial, Thorax, vol.64, issue.7, pp.561-566, 2009.
DOI : 10.1136/thx.2008.108274

E. Crisafulli, G. Manni, and M. Kidonias, Subjective Sleep Quality During Average Volume Assured Pressure Support (AVAPS) Ventilation in Patients with Hypercapnic COPD: A Physiological Pilot Study, Lung, vol.103, issue.4, pp.299-305, 2009.
DOI : 10.1007/s00408-009-9167-1

S. Scharf, N. Maimon, and T. Simon-tuval, Sleep quality predicts quality of life in chronic obstructive pulmonary disease, International Journal of Chronic Obstructive Pulmonary Disease, vol.6, pp.1-12, 2010.
DOI : 10.2147/COPD.S15666

D. Nunes, R. Mota, . De-pontes, and O. Neto, Impaired Sleep Reduces Quality of Life in Chronic Obstructive Pulmonary Disease, Lung, vol.2, issue.11, pp.159-163, 2009.
DOI : 10.1007/s00408-009-9147-5

T. Roth, Hypnotic use for insomnia management in chronic obstructive pulmonary disease, Sleep Medicine, vol.10, issue.1, pp.19-25, 2009.
DOI : 10.1016/j.sleep.2008.06.005

G. Stege, P. Vos, and F. Van-den-elshout, Sleep, hypnotics and chronic obstructive pulmonary disease, Respiratory Medicine, vol.102, issue.6, pp.801-814, 2008.
DOI : 10.1016/j.rmed.2007.12.026

G. Stege, Y. Heijdra, and F. Van-den-elshout, Temazepam 10mg does not affect breathing and gas exchange in patients with severe normocapnic COPD, Respiratory Medicine, vol.104, issue.4, pp.518-524, 2010.
DOI : 10.1016/j.rmed.2009.10.022

M. Bednarek, R. Plywaczewski, and L. Jonczak, There Is No Relationship between Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea Syndrome: A Population Study, Respiration, vol.72, issue.2, pp.142-149, 2005.
DOI : 10.1159/000084044

A. Chaouat, E. Weitzenblum, and J. Krieger, Association of chronic obstructive pulmonary disease and sleep apnea syndrome., American Journal of Respiratory and Critical Care Medicine, vol.151, issue.1, pp.82-86, 1995.
DOI : 10.1164/ajrccm.151.1.7812577

I. Hawry?kiewicz, P. Sliwin´skisliwin´sliwin´ski, and D. Gó-recka, Pulmonary haemodynamics in patients with OSAS or an overlap syndrome, Monaldi Archives for Chest Disease, vol.61, issue.3, pp.148-152, 2004.
DOI : 10.4081/monaldi.2004.693

J. Marin, J. Soriano, and S. Carrizo, Outcomes in Patients with Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea, American Journal of Respiratory and Critical Care Medicine, vol.182, issue.3, pp.325-331, 2010.
DOI : 10.1164/rccm.200912-1869OC

W. Mcnicholas, Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea, American Journal of Respiratory and Critical Care Medicine, vol.180, issue.8, pp.692-700, 2009.
DOI : 10.1164/rccm.200903-0347PP

M. Machado, W. Vollmer, and S. Togeiro, CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD, European Respiratory Journal, vol.35, issue.1, pp.132-137, 2010.
DOI : 10.1183/09031936.00192008

E. Weitzenblum, A. Chaouat, and R. Kessler, Overlap Syndrome: Obstructive Sleep Apnea in Patients with Chronic Obstructive Pulmonary Disease, Proceedings of the American Thoracic Society, vol.5, issue.2, pp.237-241, 2008.
DOI : 10.1513/pats.200706-077MG

C. Cote, M. Zilberberg, and S. Mody, Haemoglobin level and its clinical impact in a cohort of patients with COPD, European Respiratory Journal, vol.29, issue.5, pp.923-929, 2007.
DOI : 10.1183/09031936.00137106

A. 184-chambellan, E. Chailleux, and T. Similowski, Prognostic Value of the Hematocrit in Patients With Severe COPD Receiving Long-term Oxygen Therapy, Chest, vol.128, issue.3, pp.1201-1208, 2005.
DOI : 10.1378/chest.128.3.1201

M. John, A. Lange, and S. Hoernig, Prevalence of anemia in chronic obstructive pulmonary disease: Comparison to other chronic diseases, International Journal of Cardiology, vol.111, issue.3, pp.365-370, 2006.
DOI : 10.1016/j.ijcard.2005.07.043

G. Weiss and L. Goodnough, Anemia of Chronic Disease, New England Journal of Medicine, vol.352, issue.10, pp.1011-1023, 2005.
DOI : 10.1056/NEJMra041809

M. John, S. Hoernig, and W. Doehner, Anemia and Inflammation in COPD, Chest, vol.127, issue.3, pp.825-829, 2005.
DOI : 10.1378/chest.127.3.825

D. Markoulaki, K. Kostikas, and G. Papatheodorou, Hemoglobin, erythropoietin and systemic inflammation in exacerbations of chronic obstructive pulmonary disease, European Journal of Internal Medicine, vol.22, issue.1, pp.103-107, 2011.
DOI : 10.1016/j.ejim.2010.07.010

H. Moschovitis, G. Kuster, and G. , The prevalence of anemia in chronic heart failure, Int J Cardiol, vol.86, pp.115-121, 2002.

N. Cromie, C. Lee, and A. Struthers, Anaemia in chronic heart failure: what is its frequency in the UK and its underlying causes?, Heart, vol.87, issue.4, pp.377-378, 2002.
DOI : 10.1136/heart.87.4.377

J. Ezekowitz, F. Mcalister, and P. Armstrong, Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes: Insights From a Cohort of 12 065 Patients With New-Onset Heart Failure, Circulation, vol.107, issue.2, pp.223-225, 2003.
DOI : 10.1161/01.CIR.0000052622.51963.FC

D. Okonko and S. Anker, Anemia in chronic heart failure: pathogenetic mechanisms, Journal of Cardiac Failure, vol.10, issue.1, pp.5-9, 2004.
DOI : 10.1016/j.cardfail.2004.01.004

G. Krishnan, B. Grant, and P. Muti, Association between anemia and quality of life in a population sample of individuals with chronic obstructive pulmonary disease, BMC Pulmonary Medicine, vol.52, issue.10, p.23, 2006.
DOI : 10.1136/thx.52.10.879

B. Schonhofer, M. Wenzel, and M. Geibel, Blood transfusion and lung function in chronically anemic patients with severe chronic obstructive pulmonary disease, Critical Care Medicine, vol.26, issue.11, pp.1824-1828, 1998.
DOI : 10.1097/00003246-199811000-00022

P. Van-der-meer, H. Groenveld, J. Januzzi, and . Jr, Erythropoietin treatment in patients with chronic heart failure: a meta-analysis, Heart, vol.95, issue.16, pp.1309-1314, 2009.
DOI : 10.1136/hrt.2008.161091

G. Washko, G. Hunninghake, and I. Fernandez, Lung Volumes and Emphysema in Smokers with Interstitial Lung Abnormalities, New England Journal of Medicine, vol.364, issue.10, pp.897-906, 2011.
DOI : 10.1056/NEJMoa1007285

V. Cottin, H. Nunes, and P. Brillet, Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity, European Respiratory Journal, vol.26, issue.4, pp.586-593, 2005.
DOI : 10.1183/09031936.05.00021005

V. Cottin, Pragmatic prognostic approach of rheumatoid arthritis-associated interstitial lung disease, European Respiratory Journal, vol.35, issue.6, pp.1206-1208, 2010.
DOI : 10.1183/09031936.00008610

Y. Kitaguchi, K. Fujimoto, and M. Hanaoka, Clinical characteristics of combined pulmonary fibrosis and emphysema, Respirology, vol.3, issue.2, pp.265-271, 2010.
DOI : 10.1111/j.1440-1843.2009.01676.x

A. Agusti, P. Calverley, and B. Celli, Characterisation of COPD heterogeneity in the ECLIPSE cohort, Respiratory Research, vol.182, issue.5, p.122, 2010.
DOI : 10.1164/rccm.200912-1843CC

P. Burgel, N. Roche, and J. Paillasseur, Clinical COPD phenotypes identified by cluster analysis: validation with mortality, European Respiratory Journal, vol.40, issue.2, pp.495-496, 2012.
DOI : 10.1183/09031936.00228511

J. Wedzicha, T. Seemungal, and P. Maccallum, Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels, Thromb Haemost, vol.84, pp.210-215, 2000.

E. Drost, K. Skwarski, and J. Sauleda, Oxidative stress and airway inflammation in severe exacerbations of COPD, Thorax, vol.60, issue.4, pp.293-300, 2005.
DOI : 10.1136/thx.2004.027946

G. Donaldson, J. Hurst, and C. Smith, Increased Risk of Myocardial Infarction and Stroke Following Exacerbation of COPD, Chest, vol.137, issue.5, pp.1091-1097, 2010.
DOI : 10.1378/chest.09-2029

H. Kiyokawa, S. Muro, and T. Oguma, Impact of COPD Exacerbations on Osteoporosis Assessed by Chest CT Scan, COPD: Journal of Chronic Obstructive Pulmonary Disease, vol.67, issue.8, pp.235-242, 2012.
DOI : 10.1097/MCP.0b013e3282f4efb6

M. Vermeeren, A. Schols, and E. Wouters, Effects of an acute exacerbation on nutritional and metabolic profile of patients with COPD, European Respiratory Journal, vol.10, issue.10, pp.2264-2269, 1997.
DOI : 10.1183/09031936.97.10102264

B. Zvezdin, S. Milutinov, and M. Kojicic, A Postmortem Analysis of Major Causes of Early Death in Patients Hospitalized With COPD Exacerbation, Chest, vol.136, issue.2, pp.376-380, 2009.
DOI : 10.1378/chest.08-2918

I. Dahlén and C. Janson, Anxiety and Depression are Related to the Outcome of Emergency Treatment in Patients with Obstructive Pulmonary Disease, Chest, vol.122, issue.5, pp.1633-1637, 2002.
DOI : 10.1378/chest.122.5.1633

G. Gudmundsson, T. Gislason, and C. Janson, Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression, European Respiratory Journal, vol.26, issue.3, pp.414-419, 2005.
DOI : 10.1183/09031936.05.00078504

A. Papaioannou, K. Bartziokas, and S. Tsikrika, The impact of depressive symptoms on recovery and outcome of hospitalised COPD exacerbations, European Respiratory Journal, vol.41, issue.4, pp.815-823, 2013.
DOI : 10.1183/09031936.00013112

E. Küpeli, G. Ulubay, and S. Ulasli, Metabolic Syndrome is associated with increased risk of acute exacerbation of COPD: a preliminary study, Endocrine, vol.26, issue.3, pp.76-82, 2010.
DOI : 10.1007/s12020-010-9351-3